secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001425450-24-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics FY 2023 revenue $148.7M (+22% YoY); guides FY 2024 rev $197-200M
--------------------------------------------------------------------------------

- FY 2023 net loss $21.0M ($0.92/share) vs net income $1.3M ($0.06) in 2022; adjusted EBITDA rose to $5.0M from $0.2M.
- Q4 2023 revenue $37.6M (+21% YoY); gross margin 71.0% vs 68.5%; U.S. revenue +24%, international +13%.
- FY 2024 revenue guidance $197-200M (+32-34%); adjusted EBITDA guidance $8-9M.
- Acquired Boston Orthotics & Prosthetics with $80M debt financing; post-close cash ~$60M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000010/0001425450-24-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000010/kids-20240306.htm
  HTML page:      https://secwatch.observer/filing/0001425450-24-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer